Mahkam Zanganeh - Apr 29, 2025 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Co-Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Mahkam Zanganeh
Stock symbol
SMMT
Transactions as of
Apr 29, 2025
Transactions value $
$0
Form type
4
Date filed
5/1/2025, 06:03 PM
Previous filing
Apr 9, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +1.04M 1.04M Apr 29, 2025 Common Stock 1.04M $1.06 Direct F1, F2
transaction SMMT Stock Option (right to buy) Award +400K 400K Apr 29, 2025 Common Stock 400K $1.29 Direct F1, F2
transaction SMMT Stock Option (right to buy) Award +9.59M 9.59M Apr 29, 2025 Common Stock 9.59M $1.68 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025.
F2 Not applicable.